[CLOSED] Call for Applications: Professor Position in the Division of Cancer Immune Regulation

This Call for Applications is now closed, but we are permanently recruiting. Please contact us!

More

Donation from JCR Pharma Ltd.

Donation from JCR Pharma Ltd. to the "Tasuku Honjo Volunteer Fund" and the "Cancer Immunotherapy Research Fund" through a third-party allocation of treasury shares.

More

Rethinking the Immune Response as Metabolic Process

Immune responses are energetically expensive. Not surprisingly, secreted metabolites are increasingly emerging as important factors in immune cell maturation and activation, as this new review by Sidonia Fagarasan et al. demonstrates.

More

Spermidine to the Rescue?

Spermidine, a polyamine compound found in ribosomes and living tissues and originally isolated from semen, can enhance cancer immunotherapy blocking the PD-1 pathway by reversing aging effects in killer T-cells.

More

Groundbreaking Ceremony for the new CCII Research Building

A groundbreaking ceremony was held on 9th May 2022 for the Bristol Myers Squibb Building, the new home for CCII, to be constructed in the south-eastern part of the medical school campus.

More